Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

April 2021

April 21, 2021

NCI Launches the Cancer Moonshot SM Biobank to Accelerate Research in Cancer Treatment

By

Evolving Standards of Care

The U.S. National Cancer Institute (NCI) Cancer Moonshot Biobank launched in September 2020, with the aim of accelerating cancer research by creating a resource of well-annotated, longitudinal cancer biospecimens from […]
April 21, 2021

Consortium of Advocacy Groups, Professional Societies, and Industry Develops Consistent Language for Cancer Precision Medicine Testing

By

Patient Advocacy

In recent years, precision medicine has begun to play an increasingly important role in cancer care. Advanced diagnostic testing, including testing for somatic mutations, non-genomic biomarkers, and germline mutations, is […]

April 9, 2021

Immunotherapy Use in Patients With Lung Cancer and Comorbidities

By

Mitchell von Itzstein, et al.

Evolving Standards of Care

Because nearly one-half of patients with advanced cancer are eligible for immune checkpoint inhibitor (ICI)–based treatment, these therapies are now in widespread clinical use.1 ICIs—whether as monotherapy, in checkpoint inhibitor […]
April 9, 2021

ASCO and Ontario Health Publish Joint Guideline Update on Systemic Therapy for Stage IV NSCLC

By

Evolving Standards of Care

In February 2021, the American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) published a joint guideline update to the 2017 ASCO guidelines regarding systemic therapy for […]
April 9, 2021

Voice from Asia: Combination of Immune Checkpoint Inhibitors With Chemotherapy for Advanced Non-squamous NSCLC

By

Weigang Xiu, MD, PhD, et al.

Evolving Standards of Care

The immune checkpoint inhibitors (ICIs) monotherapy has resulted in significant improvements in PFS and OS in advanced NSCLC when compared with chemotherapy alone, and it has become the standard of […]

April 8, 2021

Deeper Dive Toxicity of Lung SBRT and Concurrent Immunotherapy Combinations: What We Know and What We Still Need to Learn

By

Sibo Tian, MD, et al.

Radiation Oncology

In Reference To: Tian S, Switchenko JM, Buchwald ZS, et al. Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis. Int J Radiat Oncol Biol Phys. 2020;108(1):304-313.
April 6, 2021

The IASLC Mourns the Loss of Dr. Pierre Massion

By

Names & News

“Pierre was not only an amazing physician and scientist, but he was also a truly amazing, kind, generous, and loving soul who always had a smile on his face and a kind word for everyone he met.”